Meeting Coverage:

American Academy of Ophthalmology

AAO: 2015

A Novel IOL Implant

Show Description +

Mark Kontos, MD, asks Louis D. “Skip” Nichamin, MD, about his study on a new accommodating IOL. The three-dimensional lens is a hydrophobic acrylic body filled with silicone oil, which Dr. Nichamin thinks could be the most novel IOL implant he has seen, citing data that spans 24 months.

Posted: 11/16/2015

Up Next

Placing iStents: Potential Challenges

Steven Sarkisian, MD, Steven Vold, MD


Advances With 24-Hour IOP Monitoring

Kaweh Mansouri, MD, Ranna Jaraha

New Technique for Lens Rescue

Jonathan L. Prenner, MD, Richard S. Kaiser, MD

Role-Playing: Difficult Scenarios

Christopher Starr, MD, Neda Shamie, MD

Phakic IOLs: What's Now, What's Next

Allon Barsam, MB, BS, MA, FRCOphth, Ranna Jaraha

Predictive Modeling for Lens Position

John Davidson, MD, Joseph J.K. Ma, MD, FRCSC

PVR Prevention: Identifying High-Risk Features

Jonathan L. Prenner, MD, Richard S. Kaiser, MD

Protocol S

Jeffrey Gross, MD, Scott Krzywonos

Anti-VEGF with Targeted PRP

David M. Brown, MD, Jonathan L. Prenner, MD

Optimum Timing: Pars Plana Vitrectomy

Caroline Baumal, MD , Richard Kaiser, MD

YAG Rates: Femto vs Phaco

Dan B. Tran, MD, Sonia Manning, MD

An Important Diagnosis: Conjunctival Melanoma

Carol L. Shields, MD, Mark Kontos, MD

Cross-Linking for Keratoconus

Parag Majmudar MD, Terry Kim, MD

A Novel IOL Implant

Mark Kontos, MD, asks Louis D. “Skip” Nichamin, MD, about his study on a new accommodating IOL. The three-dimensional lens is a hydrophobic acrylic body filled with silicone oil, which Dr. Nichamin thinks could be the most novel IOL implant he has seen, citing data that spans 24 months.

Posted: 11/16/2015


Please log in to leave a comment.

Comments

niveditha narayanan

9 years ago

Is it foldable iol that can be inseted through 2.2 mm incision?

Steven Hantman

9 years ago

Looking forward to seeing this lens!

More From AAO: 2015 Coverage

Protocol S

Jeffrey Gross, MD, Scott Krzywonos

Anti-VEGF with Targeted PRP

David M. Brown, MD, Jonathan L. Prenner, MD

Optimum Timing: Pars Plana Vitrectomy

Caroline Baumal, MD , Richard Kaiser, MD